Vivo Capital’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-294,909
| Closed | -$9.87M | – | 50 |
|
|
2026
Q1 | $9.87M | Sell |
294,909
-600,000
| -67% | -$23.5M | 0.82% | 31 |
|
|
2025
Q4 | $41.4M | Sell |
894,909
-1,383,294
| -61% | -$75.8M | 2.68% | 12 |
|
|
2025
Q3 | $154M | Sell |
2,278,203
-1,680,091
| -42% | -$125M | 12.39% | 1 |
|
|
2025
Q2 | $332M | Sell |
3,958,294
-500,000
| -11% | -$37.4M | 33.94% | 1 |
|
|
2025
Q1 | $319M | Sell |
4,458,294
-1,833,557
| -29% | -$89.3M | 42.19% | 1 |
|
|
2024
Q4 | $283M | Hold |
6,291,851
| – | – | 31.68% | 1 |
|
|
2024
Q3 | $318M | Sell |
6,291,851
-1,025,000
| -14% | -$49.1M | 26.29% | 1 |
|
|
2024
Q2 | $299M | Sell |
7,316,851
-1,101,242
| -13% | -$46.7M | 27.58% | 1 |
|
|
2024
Q1 | $360M | Hold |
8,418,093
| – | – | 28.31% | 1 |
|
|
2023
Q4 | $339M | Buy |
8,418,093
+5,215,000
| +163% | +$148M | 27.74% | 1 |
|
|
2023
Q3 | $94.5M | Buy |
+3,203,093
| New | +$19.4M | 10.36% | 2 |
|
|
2020
Q2 | – | Sell |
-134,758
| Closed | -$4.81M | – | 57 |
|
|
2020
Q1 | $4.81M | Buy |
+134,758
| New | +$5.73M | 0.44% | 41 |
|
|
2019
Q3 | – | Sell |
-284,597
| Closed | -$12M | – | 26 |
|
|
2019
Q2 | $12M | Sell |
284,597
-6,049
| -2% | -$209K | 1.12% | 24 |
|
|
2019
Q1 | $8.98M | Hold |
290,646
| – | – | 0.9% | 29 |
|
|
2018
Q4 | $7.46M | Hold |
290,646
| – | – | 0.95% | 27 |
|
|
2018
Q3 | $9.42M | Hold |
290,646
| – | – | 0.95% | 27 |
|
|
2018
Q2 | $10.2M | Buy |
290,646
+21,744
| +8% | +$638K | 1.31% | 21 |
|
|
2018
Q1 | $7.31M | Hold |
268,902
| – | – | 1.04% | 20 |
|
|
2017
Q4 | $7.26M | Buy |
268,902
+72,965
| +37% | +$2.1M | 1.56% | 17 |
|
|
2017
Q3 | $7.64M | Hold |
195,937
| – | – | 1.54% | 16 |
|
|
2017
Q2 | $7.36M | Hold |
195,937
| – | – | 1.85% | 12 |
|
|
2017
Q1 | $10.4M | Buy |
195,937
+96,511
| +97% | +$5.69M | 3.07% | 9 |
|
|
2016
Q4 | $6.04M | Hold |
99,426
| – | – | 1.99% | 14 |
|
|
2016
Q3 | $6.71M | Hold |
99,426
| – | – | 2.09% | 13 |
|
|
2016
Q2 | $8.65M | Sell |
99,426
-125
| -0.1% | -$11.4K | 2.36% | 10 |
|
|
2016
Q1 | $8.88M | Buy |
+99,551
| New | +$9.75M | 2.23% | 13 |
|
Vivo Capital's SLNO Position: Q2 2026 in Review
Vivo Capital sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 294,909 shares — an estimated $9.87M sold.
Vivo Capital first reported a position in SLNO in Q1 2016 and held it in 26 quarters. The position peaked at $360M in Q1 2024. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.
- Vivo Capital reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
- Vivo Capital sold 294,909 Soleno Therapeutics shares in Q2 2026, an estimated $9.87M.
- Vivo Capital first reported a position in Soleno Therapeutics in Q1 2016 and held it in 26 quarters.
- Vivo Capital's Soleno Therapeutics position peaked at $360M in Q1 2024.
- 0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.
Based on Vivo Capital's 13F filing for Q2 2026, filed 14 Aug 2026.